Pfizer launches RSV awareness campaign in UAE to help safeguard your health

Press release

Published May 1st, 2024 - 08:42 GMT

Pfizer launches RSV awareness campaign in UAE to help safeguard your health

Highlights

• RSV or Respiratory Syncytial Virus is a common respiratory virus that typically causes mild to severe, cold-like symptoms

• Through collaborative efforts with Healthcare Professionals, Pfizer hosted a media roundtable in UAE aimed at raising awareness about Respiratory Syncytial Virus (RSV) prevention

Dubai, UAE – 30 April 2024: Pfizer launched a comprehensive awareness campaign in UAE to raise awareness on Respiratory Syncytial Virus (RSV) and the proactive measures that can be taken to help prevent this disease and keep your loved ones healthy and happy. Through collaborative efforts with Healthcare Professionals, Pfizer hosted an informative media roundtable aimed to highlight the importance of safeguarding your loved ones from RSV, understand RSV, its burden and symptoms.

RSV is a contagious virus and a common cause of respiratory illness. c , . Although the virus usually results in mild, cold-like symptoms such as a runny nose, sore throat, cough and headache, it can occasionally be severe . RSV can also cause more severe infections such as bronchiolitis, an inflammation of the small airways in the lung, and pneumonia, an infection of the lungs .

Dr. Shiva Shankar, Head of Neonatology at Latifa Hospital, said: “RSV can lead to destruction and loss of cells lining the airway, inflammation in the airways, as well as mucus production, causing some to have difficulty breathing, requiring hospitalization and sometimes admission to intensive care and use of a ventilator.”

Dr. Muna Tahlak, Chief Executive Officer, at Latifa Hospital, Obstetrics and Gynecology Consultant commented: We are excited to collaborate with Pfizer in hosting this important media roundtable on RSV awareness. By joining forces, we can amplify our efforts to educate and inform the public about the significance of RSV and the precautionary measures that can be taken to prevent the spread of this virus.”

Dr. Nadine Tarcha, Gulf Medical Director, Pfizer, commented: “Pfizer is working tirelessly to research and develop breakthroughs that may help safeguard people from certain diseases. Pfizer is at the forefront of this field, focused on developing new ways of preventing diseases such as RSV that might affect millions of people around the world.”

Pfizer’s RSV comprehensive campaign will include a series of year-round initiatives and collaborations with healthcare professionals to raise awareness about RSV prevention and ensure that families are well-informed about precautionary measures that need to be taken.
To help stay ahead of RSV, keep up with your regular wellness visits and talk to your healthcare provider to help protect your loved ones.

Background Information

Pfizer

At Pfizer, it applies science and its global resources to improve health and well-being at every stage of life. It strives to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Its diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of its time. Consistent with its responsibility as the world’s leading biopharmaceutical company, it also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on them.